COVID-19 Impact on Global Premix Insulin Market Size, Status and Forecast 2020-2026

August 2020 | 93 pages | ID: CDBA7F275CDCEN
QYResearch

Abstracts

This report focuses on the global Premix Insulin status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Premix Insulin development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Novo Nordisk
• Eli Lilly
• Teva
• Pfizer
• Sanofi

Market segment by Type, the product can be split into

• Premixed Human Insulin
• Premixed Insulin Analogues

Market segment by Application, split into

• Home Use
• Medical Institutions
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Premix Insulin status, future forecast, growth opportunity, key market and key players.
• To present the Premix Insulin development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Premix Insulin are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Premix Insulin Revenue
1.4 Market Analysis by Type
  1.4.1 Global Premix Insulin Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Premixed Human Insulin
  1.4.3 Premixed Insulin Analogues
1.5 Market by Application
  1.5.1 Global Premix Insulin Market Share by Application: 2020 VS 2026
  1.5.2 Home Use
  1.5.3 Medical Institutions
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Premix Insulin Industry Impact
  1.6.1 How the Covid-19 is Affecting the Premix Insulin Industry
    1.6.1.1 Premix Insulin Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Premix Insulin Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Premix Insulin Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Premix Insulin Market Perspective (2015-2026)
2.2 Premix Insulin Growth Trends by Regions
  2.2.1 Premix Insulin Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Premix Insulin Historic Market Share by Regions (2015-2020)
  2.2.3 Premix Insulin Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Premix Insulin Market Growth Strategy
  2.3.6 Primary Interviews with Key Premix Insulin Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Premix Insulin Players by Market Size
  3.1.1 Global Top Premix Insulin Players by Revenue (2015-2020)
  3.1.2 Global Premix Insulin Revenue Market Share by Players (2015-2020)
  3.1.3 Global Premix Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Premix Insulin Market Concentration Ratio
  3.2.1 Global Premix Insulin Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Premix Insulin Revenue in 2019
3.3 Premix Insulin Key Players Head office and Area Served
3.4 Key Players Premix Insulin Product Solution and Service
3.5 Date of Enter into Premix Insulin Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Premix Insulin Historic Market Size by Type (2015-2020)
4.2 Global Premix Insulin Forecasted Market Size by Type (2021-2026)

5 PREMIX INSULIN BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Premix Insulin Market Size by Application (2015-2020)
5.2 Global Premix Insulin Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Premix Insulin Market Size (2015-2020)
6.2 Premix Insulin Key Players in North America (2019-2020)
6.3 North America Premix Insulin Market Size by Type (2015-2020)
6.4 North America Premix Insulin Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Premix Insulin Market Size (2015-2020)
7.2 Premix Insulin Key Players in Europe (2019-2020)
7.3 Europe Premix Insulin Market Size by Type (2015-2020)
7.4 Europe Premix Insulin Market Size by Application (2015-2020)

8 CHINA

8.1 China Premix Insulin Market Size (2015-2020)
8.2 Premix Insulin Key Players in China (2019-2020)
8.3 China Premix Insulin Market Size by Type (2015-2020)
8.4 China Premix Insulin Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Premix Insulin Market Size (2015-2020)
9.2 Premix Insulin Key Players in Japan (2019-2020)
9.3 Japan Premix Insulin Market Size by Type (2015-2020)
9.4 Japan Premix Insulin Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Premix Insulin Market Size (2015-2020)
10.2 Premix Insulin Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Premix Insulin Market Size by Type (2015-2020)
10.4 Southeast Asia Premix Insulin Market Size by Application (2015-2020)

11 INDIA

11.1 India Premix Insulin Market Size (2015-2020)
11.2 Premix Insulin Key Players in India (2019-2020)
11.3 India Premix Insulin Market Size by Type (2015-2020)
11.4 India Premix Insulin Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Premix Insulin Market Size (2015-2020)
12.2 Premix Insulin Key Players in Central & South America (2019-2020)
12.3 Central & South America Premix Insulin Market Size by Type (2015-2020)
12.4 Central & South America Premix Insulin Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Novo Nordisk
  13.1.1 Novo Nordisk Company Details
  13.1.2 Novo Nordisk Business Overview and Its Total Revenue
  13.1.3 Novo Nordisk Premix Insulin Introduction
  13.1.4 Novo Nordisk Revenue in Premix Insulin Business (2015-2020))
  13.1.5 Novo Nordisk Recent Development
13.2 Eli Lilly
  13.2.1 Eli Lilly Company Details
  13.2.2 Eli Lilly Business Overview and Its Total Revenue
  13.2.3 Eli Lilly Premix Insulin Introduction
  13.2.4 Eli Lilly Revenue in Premix Insulin Business (2015-2020)
  13.2.5 Eli Lilly Recent Development
13.3 Teva
  13.3.1 Teva Company Details
  13.3.2 Teva Business Overview and Its Total Revenue
  13.3.3 Teva Premix Insulin Introduction
  13.3.4 Teva Revenue in Premix Insulin Business (2015-2020)
  13.3.5 Teva Recent Development
13.4 Pfizer
  13.4.1 Pfizer Company Details
  13.4.2 Pfizer Business Overview and Its Total Revenue
  13.4.3 Pfizer Premix Insulin Introduction
  13.4.4 Pfizer Revenue in Premix Insulin Business (2015-2020)
  13.4.5 Pfizer Recent Development
13.5 Sanofi
  13.5.1 Sanofi Company Details
  13.5.2 Sanofi Business Overview and Its Total Revenue
  13.5.3 Sanofi Premix Insulin Introduction
  13.5.4 Sanofi Revenue in Premix Insulin Business (2015-2020)
  13.5.5 Sanofi Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Premix Insulin Key Market Segments
Table 2. Key Players Covered: Ranking by Premix Insulin Revenue
Table 3. Ranking of Global Top Premix Insulin Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Premix Insulin Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Premixed Human Insulin
Table 6. Key Players of Premixed Insulin Analogues
Table 7. COVID-19 Impact Global Market: (Four Premix Insulin Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Premix Insulin Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Premix Insulin Players to Combat Covid-19 Impact
Table 12. Global Premix Insulin Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Premix Insulin Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Premix Insulin Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Premix Insulin Market Share by Regions (2015-2020)
Table 16. Global Premix Insulin Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Premix Insulin Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Premix Insulin Market Growth Strategy
Table 22. Main Points Interviewed from Key Premix Insulin Players
Table 23. Global Premix Insulin Revenue by Players (2015-2020) (Million US$)
Table 24. Global Premix Insulin Market Share by Players (2015-2020)
Table 25. Global Top Premix Insulin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premix Insulin as of 2019)
Table 26. Global Premix Insulin by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Premix Insulin Product Solution and Service
Table 29. Date of Enter into Premix Insulin Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Premix Insulin Market Size by Type (2015-2020) (Million US$)
Table 32. Global Premix Insulin Market Size Share by Type (2015-2020)
Table 33. Global Premix Insulin Revenue Market Share by Type (2021-2026)
Table 34. Global Premix Insulin Market Size Share by Application (2015-2020)
Table 35. Global Premix Insulin Market Size by Application (2015-2020) (Million US$)
Table 36. Global Premix Insulin Market Size Share by Application (2021-2026)
Table 37. North America Key Players Premix Insulin Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Premix Insulin Market Share (2019-2020)
Table 39. North America Premix Insulin Market Size by Type (2015-2020) (Million US$)
Table 40. North America Premix Insulin Market Share by Type (2015-2020)
Table 41. North America Premix Insulin Market Size by Application (2015-2020) (Million US$)
Table 42. North America Premix Insulin Market Share by Application (2015-2020)
Table 43. Europe Key Players Premix Insulin Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Premix Insulin Market Share (2019-2020)
Table 45. Europe Premix Insulin Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Premix Insulin Market Share by Type (2015-2020)
Table 47. Europe Premix Insulin Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Premix Insulin Market Share by Application (2015-2020)
Table 49. China Key Players Premix Insulin Revenue (2019-2020) (Million US$)
Table 50. China Key Players Premix Insulin Market Share (2019-2020)
Table 51. China Premix Insulin Market Size by Type (2015-2020) (Million US$)
Table 52. China Premix Insulin Market Share by Type (2015-2020)
Table 53. China Premix Insulin Market Size by Application (2015-2020) (Million US$)
Table 54. China Premix Insulin Market Share by Application (2015-2020)
Table 55. Japan Key Players Premix Insulin Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Premix Insulin Market Share (2019-2020)
Table 57. Japan Premix Insulin Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Premix Insulin Market Share by Type (2015-2020)
Table 59. Japan Premix Insulin Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Premix Insulin Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Premix Insulin Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Premix Insulin Market Share (2019-2020)
Table 63. Southeast Asia Premix Insulin Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Premix Insulin Market Share by Type (2015-2020)
Table 65. Southeast Asia Premix Insulin Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Premix Insulin Market Share by Application (2015-2020)
Table 67. India Key Players Premix Insulin Revenue (2019-2020) (Million US$)
Table 68. India Key Players Premix Insulin Market Share (2019-2020)
Table 69. India Premix Insulin Market Size by Type (2015-2020) (Million US$)
Table 70. India Premix Insulin Market Share by Type (2015-2020)
Table 71. India Premix Insulin Market Size by Application (2015-2020) (Million US$)
Table 72. India Premix Insulin Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Premix Insulin Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Premix Insulin Market Share (2019-2020)
Table 75. Central & South America Premix Insulin Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Premix Insulin Market Share by Type (2015-2020)
Table 77. Central & South America Premix Insulin Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Premix Insulin Market Share by Application (2015-2020)
Table 79. Novo Nordisk Company Details
Table 80. Novo Nordisk Business Overview
Table 81. Novo Nordisk Product
Table 82. Novo Nordisk Revenue in Premix Insulin Business (2015-2020) (Million US$)
Table 83. Novo Nordisk Recent Development
Table 84. Eli Lilly Company Details
Table 85. Eli Lilly Business Overview
Table 86. Eli Lilly Product
Table 87. Eli Lilly Revenue in Premix Insulin Business (2015-2020) (Million US$)
Table 88. Eli Lilly Recent Development
Table 89. Teva Company Details
Table 90. Teva Business Overview
Table 91. Teva Product
Table 92. Teva Revenue in Premix Insulin Business (2015-2020) (Million US$)
Table 93. Teva Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Product
Table 97. Pfizer Revenue in Premix Insulin Business (2015-2020) (Million US$)
Table 98. Pfizer Recent Development
Table 99. Sanofi Company Details
Table 100. Sanofi Business Overview
Table 101. Sanofi Product
Table 102. Sanofi Revenue in Premix Insulin Business (2015-2020) (Million US$)
Table 103. Sanofi Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Premix Insulin Market Share by Type: 2020 VS 2026
Figure 2. Premixed Human Insulin Features
Figure 3. Premixed Insulin Analogues Features
Figure 4. Global Premix Insulin Market Share by Application: 2020 VS 2026
Figure 5. Home Use Case Studies
Figure 6. Medical Institutions Case Studies
Figure 7. Others Case Studies
Figure 8. Premix Insulin Report Years Considered
Figure 9. Global Premix Insulin Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Premix Insulin Market Share by Regions: 2020 VS 2026
Figure 11. Global Premix Insulin Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Premix Insulin Market Share by Players in 2019
Figure 14. Global Top Premix Insulin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premix Insulin as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Premix Insulin Revenue in 2019
Figure 16. North America Premix Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Premix Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Premix Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Premix Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Premix Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Premix Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Premix Insulin Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Novo Nordisk Revenue Growth Rate in Premix Insulin Business (2015-2020)
Figure 25. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Eli Lilly Revenue Growth Rate in Premix Insulin Business (2015-2020)
Figure 27. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Teva Revenue Growth Rate in Premix Insulin Business (2015-2020)
Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pfizer Revenue Growth Rate in Premix Insulin Business (2015-2020)
Figure 31. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sanofi Revenue Growth Rate in Premix Insulin Business (2015-2020)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed